Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 30% ± 15% |
Insufficient scRNA-seq data for expression of CHST13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 2414.79 | 226 / 226 | 99% | 62.84 | 401 / 406 |
kidney | 97% | 231.93 | 86 / 89 | 84% | 17.31 | 758 / 901 |
intestine | 58% | 42.29 | 561 / 966 | 46% | 5.37 | 243 / 527 |
lung | 82% | 55.76 | 474 / 578 | 18% | 1.56 | 208 / 1155 |
spleen | 99% | 284.22 | 238 / 241 | 0% | 0 | 0 / 0 |
stomach | 42% | 9.20 | 151 / 359 | 53% | 7.37 | 152 / 286 |
adrenal gland | 79% | 30.51 | 204 / 258 | 13% | 0.86 | 31 / 230 |
bladder | 62% | 18.52 | 13 / 21 | 20% | 1.27 | 103 / 504 |
peripheral blood | 80% | 424.78 | 747 / 929 | 0% | 0 | 0 / 0 |
adipose | 66% | 26.49 | 800 / 1204 | 0% | 0 | 0 / 0 |
heart | 59% | 14.81 | 507 / 861 | 0% | 0 | 0 / 0 |
breast | 47% | 13.14 | 217 / 459 | 8% | 0.26 | 93 / 1118 |
esophagus | 31% | 6.98 | 444 / 1445 | 20% | 3.62 | 37 / 183 |
brain | 46% | 13.56 | 1208 / 2642 | 4% | 0.13 | 28 / 705 |
ovary | 18% | 3.64 | 33 / 180 | 30% | 1.56 | 131 / 430 |
prostate | 42% | 10.88 | 102 / 245 | 0% | 0.01 | 1 / 502 |
blood vessel | 38% | 13.21 | 505 / 1335 | 0% | 0 | 0 / 0 |
uterus | 21% | 4.15 | 35 / 170 | 13% | 0.87 | 61 / 459 |
pancreas | 15% | 3.41 | 48 / 328 | 17% | 0.90 | 31 / 178 |
skin | 19% | 4.06 | 342 / 1809 | 10% | 0.36 | 49 / 472 |
thymus | 19% | 4.02 | 123 / 653 | 8% | 0.27 | 49 / 605 |
eye | 0% | 0 | 0 / 0 | 6% | 0.18 | 5 / 80 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.20 | 2 / 45 |
muscle | 4% | 0.98 | 35 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030166 | Biological process | proteoglycan biosynthetic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0016051 | Biological process | carbohydrate biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0001537 | Molecular function | N-acetylgalactosamine 4-O-sulfotransferase activity |
GO_0008146 | Molecular function | sulfotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0047756 | Molecular function | chondroitin 4-sulfotransferase activity |
Gene name | CHST13 |
Protein name | CHST13 protein Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3) Carbohydrate sulfotransferase (EC 2.8.2.-) |
Synonyms | |
Description | FUNCTION: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Transfers sulfate to the C4 hydroxyl of beta1,4-linked GalNAc that is substituted with a beta-linked glucuronic acid at the C-3 hydroxyl. No activity toward dermatan. |
Accessions | Q3ZCU8 ENST00000319340.7 [Q8NET6-1] Q3ZCR4 Q8NET6 |